Betaine-Modified Chitosan Nanoparticles Enhance Oral Insulin Delivery via pH-Triggered Charge Switching, Mucus Penetration, and Lysosomal Escape
Authors:
- 1 August 2026
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (9) , 4482-4498
Abstract
Oral insulin delivery is limited by the intestinal mucus barrier and intracellular lysosomal degradation within epithelial cells. To address these sequential barriers, we engineered insulin-loaded zwitterionic charge-switching nanoparticles (INS/Bet-CS-SA NPs) through the rational integration of betaine-modified chitosan and sodium alginate. This design leverages the pH-responsive surface charge transition of the nanocomplex, allowing the formulation to remain compact and positively charged under gastric conditions while undergoing swelling and surface transformation in intestinal media. The optimized nanoparticles exhibited a high insulin loading capacity (71.71%) and a sustained release profile (86.03% within 12 h under simulated gastrointestinal conditions). Especially, the surface zeta potential of INS/Bet-CS-SA NPs shifted from +15.73 ± 3.17 mV at pH 1.2 to −24.22 ± 3.47 mV at pH 6.8 and −25.68 ± 3.93 mV at pH 7.4, confirming the intended charge-switching behavior. This zwitterionic functional surface markedly enhanced mucus penetration and transepithelial transport, yielding apparent permeability coefficients 25.4-fold higher than that of free insulin. Cellular uptake and trafficking analyses suggested caveolae-associated endocytosis and reduced lysosomal retention played an essential role, which might be caused by betaine-associated membrane perturbation and chitosan’s proton buffering capacity. In a type 2 diabetic rat model, orally administered INS/Bet-CS-SA NPs induced a sustained hypoglycemic response and achieved a relative bioavailability of 25.36%. The prolonged pharmacodynamic effect was additionally supported by a semimechanistic pharmacokinetic/pharmacodynamic model. Overall, this work provides a zwitterionic functional nanoplatform capable of overcoming multiple gastrointestinal barriers as a promising strategy for the oral delivery of insulin.Keywords
Funding Information
- Graduate Program in Physics at UNIFAL-MG (NA)
This publication has 58 references indexed in Scilit:
- Zwitterionic alginate derivative as a new delivery platform for enhanced blood circulationJournal of Pharmaceutical Investigation, 2024
- Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulationActa Pharmaceutica Sinica B, 2024
- Biomimetic zwitterionic copolymerized chitosan as an articular lubricantCarbohydrate Polymers, 2024
- Simultaneous electrochemical detection of glycated and human serum albumin for diabetes managementBiosensors and Bioelectronics, 2023
- Crystalline micro-nanoparticles enhance cross-linked hydrogels via a confined assembly of chitosan and γ-cyclodextrinCarbohydrate Polymers, 2022
- A multifunctional chitosan composite aerogel for PPCPs adsorptionCarbohydrate Polymers, 2022
- Chitosan oleate-tripolyphosphate complex-coated calcium alginate bead: Physicochemical aspects of concurrent core-coat formationCarbohydrate Polymers, 2021
- Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin deliveryCarbohydrate Polymers, 2020
- Conjugation of insulin-mimetic [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(II) with chitosan in aqueous solution: kinetics, equilibrium and thermodynamicsPolymer Bulletin, 2020
- How to study proteins by circular dichroismBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005